N/A β HANGZHOU BINJIANG, approved 2020-10-27 (ANDA208824).
85,823 reports across the top reactions. These are spontaneously reported events from the FDA Adverse Event Reporting System β they reflect reporting volume, not incidence or frequency, and a report does not mean the drug caused the event.